mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Inpatient statin use predicts improved ischemic stroke discharge disposition

Flint AC et al. – Statin use is strongly associated with improved discharge disposition after ischemic stroke.

Methods
  • The authors used generalized ordinal logistic regression to analyze discharge disposition among 12,689 patients with ischemic stroke over a 7–year period at 17 hospitals in an integrated care delivery system.
  • They also analyzed treatment patterns by hospital to control for the possibility of confounding at the individual patient level.

Results
  • Statin users before and during stroke hospitalization were more likely to have a good discharge outcome (odds ratio [OR] for discharge to home=1.38, 95% confidence interval [CI] 1.25–1.52, p<0.001; OR for discharge to home or institution=2.08, 95% CI 1.72–2.51, p<0.001).
  • Patients who underwent statin withdrawal were less likely to have a good discharge outcome (OR for discharge to home = 0.77, 95% CI 0.63–0.94, p = 0.012; OR for discharge to home or institution=0.43, 95% CI 0.33–0.55, p<0.001).
  • In grouped–treatment analysis, an instrumental variable method using treatment patterns by hospital, higher probability of inpatient statin use predicted a higher likelihood of discharge to home (OR =2.56, 95% CI 1.71–3.85, p < 0.001).
  • In last prior treatment analysis, a novel instrumental variable method, patients with a higher probability of statin use were more likely to have a good discharge outcome (OR for each better level of ordinal discharge outcome=1.19, 95% CI 1.09–1.30, p=0.001).
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close